A single dose of a nonsteroidal anti-inflammatory drug (NSAID) before ureteric stent removal can prevent severe pain afterwards, a study found.
In a prospective double-blind study, a team led by Michael J. Conlin, MD, of Oregon Health & Science University in Portland, enrolled 22 adult patients with an indwelling ureteric stent after ureteroscopy and randomized them to receive either a single 50 mg dose of rofecoxib or a single dose of placebo prior to stent removal. Twenty-one patients completed the study.
Severe pain (a score of 7 or higher on a visual analogue scale) during the 24 hours after stent removal was reported by six of 11 patients (55%) in the placebo group compared with none of the 10 patients in the NSAID group, the investigators reported in BJU International (2013;111:101-105).
Continue Reading
The researchers observed no complications related to rofecoxib use.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.